🇺🇸 FDA
Patent

US 11786479

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

granted A61KA61K2300/00A61K31/355

Quick answer

US patent 11786479 (Nucleic acid nanocapsules for drug delivery and targeted gene knockdown) held by UNIVERSITY OF CONNECTICUT expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2300/00, A61K31/355, A61K31/4188, A61K31/575